<ul>
<li>Prologis 股票飙升：为何这一涨势可能会持续</li>
</ul>
<p>根据 MarketBeat 的股票筛选工具，Prologis、Ascendis Pharma A/S 和 Teledyne Technologies 是今天值得关注的三只成长股。成长股是指预计收入和收益增长速度快于整体市场的公司的股票。它们通常将利润再投资于扩张，而不是支付股息，通常以更高的估值倍数交易，并吸引寻求资本增值的投资者，尽管波动性较高。这些公司在过去几天内的成长股中交易量最高。</p>
<h2>Prologis (PLD)</h2>
<p>Prologis, Inc.是全球物流房地产的领导者，专注于高壁垒、高增长市场。截至 2024 年 3 月 31 日，该公司在 19 个国家拥有或投资的物业和开发项目预计总面积约为 12 亿平方英尺（1.15 亿平方米）。</p>
<ul>
<li>3 只在市场波动中应持有的股息股票</li>
</ul>
<p>阅读我们关于 PLD 的最新研究报告</p>
<h2>Ascendis Pharma A/S (ASND)</h2>
<p>Ascendis Pharma A/S 是一家生物制药公司，专注于开发满足未满足医疗需求的疗法。它提供 SKYTROFA 用于治疗生长激素缺乏症（GHD）患者。该公司还在临床开发中开发三种独立内分泌罕见疾病产品候选药物，并专注于推进肿瘤治疗候选药物。</p>
<ul>
<li>3 只推动 AI 基础设施繁荣的云计算建设股票</li>
</ul>
<p>阅读我们关于 ASND 的最新研究报告</p>
<h2>Teledyne Technologies (TDY)</h2>
<p>Teledyne Technologies Incorporated 及其子公司为美国及国际工业增长市场提供支持技术。其数字成像部门提供可见光谱传感器和数字相机；以及红外、紫外、可见光和 X 射线光谱；以及微机电系统和半导体，包括模数转换器和数模转换器。</p>
<p>阅读我们关于 TDY 的最新研究报告</p>
<h2>另见</h2>
<ul>
<li>MarketBeat 在 2025 年 12 月的五大股票推荐</li>
<li>微软落后于市场——但其护城河在 2026 年可能更重要</li>
<li>Kroger 催化剂：20 亿美元的购买理由</li>
<li>华尔街为何放弃辉瑞——这可能是个错误</li>
<li>黄金、白银和铜价格飙升——这里有 3 种聪明的投资方式</li>
<li>在收益前的 4 周内，亚马逊会有什么表现</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Prologis 吗？</h2>
<p>在考虑 Prologis 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Prologis 并不在名单上。</p>
<p>虽然 Prologis 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

Ascendis制药

安博

<p>根据 MarketBeat 的报道，Prologis、Ascendis Pharma A/S 和 Teledyne Technologies 被强调为今天值得关注的成长股。成长股预计将超越市场的收入和盈利增长，通常会将利润再投资用于扩张。Prologis 在物流房地产领域处于领先地位，Ascendis 专注于生物制药，而 Teledyne 为工业市场提供技术。这些公司最近显示出高交易量，吸引了寻求资本增值的投资者，尽管市场波动性较大</p>

<ul>
<li>Prologis Stock Surges: Why the Rally May Continue</li>
</ul>
<div class="lb-trans"><ul>
<li>Prologis 股票飙升：为何这一涨势可能会持续</li>
</ul>
</div><p>Prologis, Ascendis Pharma A/S, and Teledyne Technologies are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow revenues and earnings faster than the overall market. They typically reinvest profits into expansion rather than paying dividends, often trade at higher valuation multiples, and appeal to investors seeking capital appreciation despite higher volatility. These companies had the highest dollar trading volume of any Growth stocks within the last several days.</p>
<div class="lb-trans"><p>根据 MarketBeat 的股票筛选工具，Prologis、Ascendis Pharma A/S 和 Teledyne Technologies 是今天值得关注的三只成长股。成长股是指预计收入和收益增长速度快于整体市场的公司的股票。它们通常将利润再投资于扩张，而不是支付股息，通常以更高的估值倍数交易，并吸引寻求资本增值的投资者，尽管波动性较高。这些公司在过去几天内的成长股中交易量最高。</p>
</div><h2>Prologis (PLD)</h2>
<div class="lb-trans"><h2>Prologis (PLD)</h2>
</div><p>Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.</p>
<div class="lb-trans"><p>Prologis, Inc.是全球物流房地产的领导者，专注于高壁垒、高增长市场。截至 2024 年 3 月 31 日，该公司在 19 个国家拥有或投资的物业和开发项目预计总面积约为 12 亿平方英尺（1.15 亿平方米）。</p>
</div><ul>
<li>3 Dividend Stocks to Hold Through Market Volatility This Fall</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只在市场波动中应持有的股息股票</li>
</ul>
</div><p>Read Our Latest Research Report on PLD</p>
<div class="lb-trans"><p>阅读我们关于 PLD 的最新研究报告</p>
</div><h2>Ascendis Pharma A/S (ASND)</h2>
<div class="lb-trans"><h2>Ascendis Pharma A/S (ASND)</h2>
</div><p>Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.</p>
<div class="lb-trans"><p>Ascendis Pharma A/S 是一家生物制药公司，专注于开发满足未满足医疗需求的疗法。它提供 SKYTROFA 用于治疗生长激素缺乏症（GHD）患者。该公司还在临床开发中开发三种独立内分泌罕见疾病产品候选药物，并专注于推进肿瘤治疗候选药物。</p>
</div><ul>
<li>3 Cloud Build-Out Stocks Behind the AI Infrastructure Boom</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只推动 AI 基础设施繁荣的云计算建设股票</li>
</ul>
</div><p>Read Our Latest Research Report on ASND</p>
<div class="lb-trans"><p>阅读我们关于 ASND 的最新研究报告</p>
</div><h2>Teledyne Technologies (TDY)</h2>
<div class="lb-trans"><h2>Teledyne Technologies (TDY)</h2>
</div><p>Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.</p>
<div class="lb-trans"><p>Teledyne Technologies Incorporated 及其子公司为美国及国际工业增长市场提供支持技术。其数字成像部门提供可见光谱传感器和数字相机；以及红外、紫外、可见光和 X 射线光谱；以及微机电系统和半导体，包括模数转换器和数模转换器。</p>
</div><p>Read Our Latest Research Report on TDY</p>
<div class="lb-trans"><p>阅读我们关于 TDY 的最新研究报告</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>MarketBeat's Top Five Stocks to Own in December 2025</li>
<li>Microsoft Is Lagging the Market—But Its Moat May Matter More in 2026</li>
<li>The Kroger Catalyst: $2 Billion Reasons to Buy</li>
<li>Why Wall Street Gave Up on Pfizer—and Why That May Be a Mistake</li>
<li>Gold, Silver, and Copper Are Surging—Here Are 3 Smart Ways to Play It</li>
<li>What to Expect From Amazon in the 4 Weeks Before Earnings</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 在 2025 年 12 月的五大股票推荐</li>
<li>微软落后于市场——但其护城河在 2026 年可能更重要</li>
<li>Kroger 催化剂：20 亿美元的购买理由</li>
<li>华尔街为何放弃辉瑞——这可能是个错误</li>
<li>黄金、白银和铜价格飙升——这里有 3 种聪明的投资方式</li>
<li>在收益前的 4 周内，亚马逊会有什么表现</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Prologis Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Prologis 吗？</h2>
</div><p>Before you consider Prologis, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Prologis 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prologis wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Prologis 并不在名单上。</p>
</div><p>While Prologis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Prologis 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

12 月 31 日值得关注的成长型股票